ALHC Mark D. Kent bought Alignment Healthcare, Inc. shares — SEC Form 4BUYAlignment Healthcare, Inc.

The stock is trading at $13.635, down 32.67% over the last 30 days and 42.88% below its 52-week high of $23.87, despite recent Q2 earnings beating revenue estimates.

• •Q2 earnings on 2026-08-01 beat revenue expectations by 31.6% and non-GAAP profit by 24.3%, with management raising full-year 2026 guidance.
• •Next earnings date on 2026-10-30 will be the first opportunity to see if second-half reinvestments impact profitability.
• •The whistleblower lawsuit investigation into accounting questions remains a key risk factor to monitor.

• •The stock is down 37.6% in the last 4 weeks, indicating heavy selling pressure that may persist.
• •A whistleblower lawsuit alleging misclassification of operating expenses as capital expenditures is currently pressuring the stock.